课题基金 / 基金详情

Role of ABH1's AP endonuclease activity in immunoglobulin gene diversification

Role of ABH1's AP endonuclease activity in immunoglobulin gene diversification
ABH1 的 AP 核酸内切酶活性在免疫球蛋白基因多样化中的作用
批准号:
7905032
负责人:
Tina A Mueller
金额:
$15.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2012-07-31

项目摘要

项目成果

Tina A Mueller的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):ABH1的AP内切酶活性在免疫球蛋白基因多样化中的作用:本研究的重点是确定ABH1(大肠杆菌AlkB DNA修复酶的哺乳动物同源物I)是否在淋巴细胞中起切割基本位点和产生断裂的作用,这些断裂是类开关重组(CSR)和基因转换(GC)所必需的中间产物,并可能在B细胞亲和成熟过程中促进某些类型的体细胞超突变(SH)。已知这些过程是由激活诱导胞苷脱氨酶(AID)作用于V区或开关区单链DNA启动的。尿嘧啶n -糖基化酶(Ung)作用于脱氨胞苷(现在是尿嘧啶)产生基位。我们最近对ABH1的生化研究表明,它具有特异性切割双链DNA碱基位点的核内溶活性。ABH1与CSR、GC或SHM之间没有直接联系的报道,但没有证据确凿地表明在这些过程中有任何已知的基本位点内切酶。如果ABH1是在发育中的B淋巴细胞中负责切割AID/Ung诱导的基础位点的酶,那么该研究将对理解B细胞分化的几个关键步骤产生重大影响,从而大大推进该领域的进展。拟建研究的具体目标是:1。从ABH1+/flox小鼠中创建ABH1-/-小鼠。2. 确定ABH1-/-小鼠B细胞的CSR是否正常进行。3. 确定ABH1-/-小鼠B细胞中SHM是否改变。公共卫生相关性:高等脊椎动物在正常环境中的生存需要高度适应性的免疫系统来产生大量不同的抗原受体。特别是,激活诱导脱氨酶(AID)和尿嘧啶DNA n-糖基化酶(Ung)在DNA中创建基本位点,这是类转换重组、基因转换和体细胞超突变所需的步骤。本研究将确定大肠杆菌AlkB DNA修复酶的人类同源物ABH1是否利用其新发现的切割DNA基本位点的能力来促进B细胞中免疫球蛋白基因的多样化系统。
英文摘要
DESCRIPTION (provided by applicant): Role of ABH1's AP endonuclease activity in immunoglobulin gene diversification: The focus of this proposal is to determine whether ABH1 (mammalian homologue I of the Escherichia coli AlkB DNA repair enzyme) functions in lymphocytes to cleave abasic sites and generate breaks that are the requisite intermediate for class switch recombination (CSR) and gene conversion (GC) and that may promote certain types of somatic hypermutations (SH) during B cell affinity maturation. These processes are known to be initiated by activation induced cytidine deaminase (AID) acting on single-stranded DNA in V or switch regions. Uracil N-glycosylase (Ung) acts on the deaminated cytidine (now a uracil) to generate an abasic site. Our recent biochemical studies of ABH1 revealed it to possess an endonucleolytic activity with specificity for cleaving at abasic sites in double-stranded DNA. No direct connection has been reported between ABH1 and CSR, GC, or SHM, but no evidence firmly implicating any known abasic site endonuclease in these processes has been forthcoming. If ABH1 is the enzyme responsible for cleaving AID/Ung induced abasic sites in developing B lymphocytes, this study will have high impact for understanding several critical steps in B cell differentiation, substantially advancing progress in the field. The specific goals of the proposed research are to: 1. Create ABH1-/- mice from ABH1+/flox mice. 2. Determine whether CSR proceeds normally in B cells from ABH1-/- mice. 3. Determine whether SHM is altered in B cells from ABH1-/- mice. PUBLIC HEALTH RELEVANCE: Survival of higher vertebrates in normal environments requires a highly adaptive immune system to generate an immense repertoire of distinct antigen receptors. In particular, activation-induced deaminase (AID) and uracil DNA N-glycosylase (Ung) create abasic sites in DNA as required steps of class switch recombination, gene conversion, and somatic hypermutation. The studies described in this proposal will identify whether ABH1, the human homologue of the Escherichia coli AlkB DNA repair enzyme, uses its newly-detected ability to cleave abasic sites of DNA to facilitate immunoglobulin gene diversification system in B cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of ABH1's AP endonuclease activity in immunoglobulin gene diversification
  • 批准号:
    7738746
  • 项目类别:
  • 资助金额:
    $19.0万
  • 财政年份:
    2009
  • 负责人:
    Tina A Mueller
  • 依托单位:
海外基金